TP53 alterations have been described in lung cancers, with the highest prevalence in small cell (>90%)6 and squamous cell carcinoma (81%)8, 9; both subtypes are most consistently associated with long‐term smoking. Here, TP53 is linked to squamous cell carcinoma.